| |
|
|
| |
Drug Coatings and Coated Device Drug
Delivery
Evolving Technology, Emerging Opportunities
|
Publication: February 2011
Product Code: DDC35F9
|
Advances in coating technology have given rise to a new
generation of coating formulations that can reliably deliver
therapeutic substances from the surface of an implanted
medical device. In currently approved products, these
devices provide a primary function, with the drug
contributing therapeutic benefit that improves patient
outcomes. We expect this trend to continue as competitors
attempt to broaden their portfolio of technology offerings
to accommodate the application needs of highly specific and
evolving therapeutic protocols. In this environment,
strategic relationships between and among drug, device and
coating companies will continue to be an essential element
of success. |
|
Highlights |
· Analyzes and evaluates
drug coating technology platforms and commercial drug
coating products assesses the market potential for
existing and probable future products
· Examines drug delivery
coating design issues and evolving market factors
· Forecasts the impact of
drug coated devices and technology on drug delivery markets and
projects probable future developments
· Provides forecasts of coated drug
product usage to 2014
• Profiles specialty drug coating market participants,
their technology, product development activity, and
business strategies
|
|
Summary of Contents |
Executive Summary
Drug Coating Market
Dynamics
The State of Drug Delivery
Therapeutics
Coated Device Drug Delivery Market
Segments
Market Drivers
Competitive Landscape
Drug Delivery Coating Design Factors
Bioavailability
Biocompatibility
Elasticity
Drug Coating Technology
Drug/Coating Matrix
Substrates
Drug Delivery Coatings - Platform
Technologies Assessment
Adapt
Amplex
Bravo
Biochronomer
Egap
Biosilicon
Eureka SOLO
Ouverture
Pacliteq
Proteqtor
Repulsion
PolyActive
SynBiosis
Drug
Delivery Coating Market Drivers
Near-term Drug
Coating Applications
Drug Delivery Coatings -
Potential Therapies, Development Programs, and
Outlook
Cancer Therapeutics
Cardiology
Gastrointestinal
Ocular
Orthopedics
Neurology
Future Markets and Market Potential
Market Factors
Regulations and Standards
Clinical Trial Process
Combination Product
Regulation
Company Profiles
|
|
|
|
|
